These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management strategies for relapsed/refractory multiple myeloma: current clinical perspectives. Jakubowiak A Semin Hematol; 2012 Jul; 49 Suppl 1():S16-32. PubMed ID: 22727389 [TBL] [Abstract][Full Text] [Related]
6. The next generation of novel therapies for the management of relapsed multiple myeloma. Gonsalves WI; Milani P; Derudas D; Buadi FK Future Oncol; 2017 Jan; 13(1):63-75. PubMed ID: 27513456 [TBL] [Abstract][Full Text] [Related]
7. Novel agents for relapsed and/or refractory multiple myeloma. Thomas SK; Richards TA; Weber DM Cancer J; 2009; 15(6):485-93. PubMed ID: 20010168 [TBL] [Abstract][Full Text] [Related]